Moors & Cabot, Inc.

Position in DGX — Quest Diagnostics Inc

CIK 1607239 BOSTON, MA

Position in DGX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$420,508

+$5,815 QoQ

Shares Held

1,984

-6.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#658

of 1,090 holders

Holding Since

Jun 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Moors & Cabot, Inc. holds $18,215,220 across 9 Diagnostics & Research names. DGX ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	QGEN	Qiagen N.V.	339,461	$13,272,925
2	TMO	Thermo Fisher Scientific Inc.	2,681	$1,344,146
3	ILMN	Illumina, Inc.	5,000	$879,150
4	WAT	Waters Corp /De/	2,019	$757,205
5	DHR	Danaher Corp /De/	3,437	$654,679
6	DGX	Quest Diagnostics Inc This page	1,984	$420,508
7	CRL	Charles River Laboratories International, Inc.	1,731	$392,573
8	RVTY	Revvity, Inc.	2,375	$264,242

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$420,508	1,984	-6.2%	Shares	Sole	2026-08-10
2026-03-31	$414,693	2,116	-20.6%	Shares	Sole	2026-05-08
2025-12-31	$462,283	2,664	+19.7%	Shares	Sole	2026-02-10
2025-09-30	$424,040	2,225	-87.7%	Shares	Sole	2025-11-14
2023-12-31	$2,488,044	18,045	+1.5%	Shares	Sole	2024-02-14
2023-09-30	$2,167,280	17,785	-2.4%	Shares	Sole	2023-11-08
2023-06-30	$2,560,159	18,214	-7.8%	Shares	Sole	2023-08-10
2023-03-31	$2,794,795	19,754	-1.9%	Shares	Sole	2023-05-05
2022-12-31	$3,149,293	20,131	0.0%	Shares	Sole	2023-02-10
2022-09-30	$2,469,872	20,131	+0.1%	Shares	Sole	2022-11-08
2022-06-30	$2,673,163	20,102	-0.8%	Shares	Sole	2022-08-08
2022-03-31	$2,771,962	20,254	-0.5%	Shares	Sole	2022-05-13
2021-12-31	$3,523,002	20,363	+0.6%	Shares	Sole	2022-02-14
2021-09-30	$2,940,929	20,239	+37.5%	Shares	Sole	2021-12-08
2021-06-30	$1,942,202	14,717	—	Shares	Sole	2021-08-10
No filing history on record for this holder in this stock.